All News

New drugs for acute migraines are almost ready for prime time. Here's what you need to know.

A study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.

If the past few weeks are any indication, pharmacy isn’t going to be the same for very long.

Andaxanet alfa has shown effectiveness for patients needing hemostasis.

Arizona joins a growing list of states to adopt telepharmacy legislation. Here’s how it could affect pharmacists.

Newly found antibody may help create effective vaccine against malaria.

Parents of children with autism spectrum disorder are less likely to fully vaccinate their autistic child or the siblings.

FDA approves apalutamide for castration-resistant prostate cancer.

Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.

Could telemedicine be the answer to diabetes management problems?

Collaboration can take pharmacists all kinds of places-but almost always results in healthier patients.

Not too long ago, it seemed like anything could end up in a pharmacy-with disastrous (or sometimes just humorous) results.

Technology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.

Pharmacists have a responsibility to help control opioid misuse, but how do you prove that you’re doing everything right?

Pharmacists urged to support controls to the marijuana market but oppose criminalization.

Affected Products Sold at Walgreens, CVS, Walmart, and Kroger Stores.

How one health system is coping is coping with the shortages.

Just like paper prescriptions, e-prescriptions still rely on clear communication.

Greater awareness of the dangers posed by prescription opioids is changing pharmacy practice.

The legalization of marijuana has consequences.

Critics point to reduced competition, higher costs.

Signs point to a cooling on the FDA's fiery approval pace of 2017, but 2018 has already seen five novel drug approvals.

Managing the overall risk of medication therapy is more effective than simply managing drug-drug interactions.

Easy-to-swallow news and studies for the busy pharmacist.

The Advisory Committee on Immunization Practices now recommends use of Shingrix for adults aged 50 and over.

Lidocaine and capsaicin patches are effective for postherpetic neuralgia.

Zinbryta was taken off the market, leaving many patients with poor options.

It's something every pharmacist knows well-the long shift. Here's how to make it a little more bearable.